S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME
oleh: Raffaele Badolato, Jean Donadieu, 4whim Study Group
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2023-08-01 |
Deskripsi
No description available for this item.